Unexpectedly, we found that PTL significantly promotes the anti-HCC effect of ATO in vivo and in vitro by further inhibiting the proliferation and self-renewal ability of HCC, blocking cell cycle, enhancing the production of ROS, and inducing mitochondrial-dependent apoptosis. Here, PNLIP is linked to hepatocellular carcinoma.